Seth Lederman Tonix Pharmaceuticals Holding Corp. (TNXP) insider trading activity

Seth Lederman is Chief Executive Officer of Tonix Pharmaceuticals Holding Corp.. Currently has a direct ownership of 5 shares of TNXP, which is worth approximately $90. The most recent transaction as insider was on Feb 05, 2025, when has been sold 5 shares (Common Stock, $0.001 par value) at a price of $3.38 per share, resulting in proceeds of $16. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5

100.0% 3M change

100.0% 12M change

Total Value Held $90

SETH LEDERMAN Transaction History

Date	Transaction	Value	Shares Traded	Shares Held	Form
Date	Transaction	Value	Shares Traded	Shares Held	Form
Feb 05 2025	SELL Other acquisition or disposition	$16 $3.38 p/Share	5 Reduced 50.0%	5 Common Stock, $0.001 p...
Mar 25 2022	BUY Open market or private purchase	$24,000 $0.24 p/Share	100,000 Added 47.13%	112,177 Common Stock, $0.001 p...
Sep 28 2021	BUY Open market or private purchase	$7,320 $0.61 p/Share	12,000 Added 49.63%	12,177 Common Stock, $0.001 p...
Dec 30 2020	BUY Open market or private purchase	$23,800 $0.68 p/Share	35,000 Added 22.84%	118,267 Common Stock, $0.001 p...

Seth Lederman

Chief Executive Officer

Chatham, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TNXP shares.

Notify only if

Value

Any

Insider Trading

Get notified when an Tonix Pharmaceuticals Holding Corp. insider buys or sells TNXP shares.

Notify only if

Operation

Any

Value

Any

Type

P - Open market or private purchase×

S - Open market or private sale×

V - Transaction voluntarily reported earlier than required×

A - Grant, award, or other acquisition×

D - Sale (or disposition) back to the issuer×

F - Payment of exercise price or tax liability×

I - Discretionary transaction×

M - Exercise of conversion of derivative security×

C - Conversion of derivative security×

E - Expiration of short derivative position×

H - Expiration (or cancellation) of long derivative position with value received×

O - Exercise of out-of-the-money derivative securities×

X - Exercise of in-the-money or at-the-money derivatives securities×

G - Bona fide gift×

L - Small Acquisition×

W - Acquisition or disposition by will or laws×

Z - Deposit into or withdrawal from voting trust×

J - Other acquisition or disposition×

K - Transaction in equity swap or similar instrument×

U - Disposition due to a tender of shares in a change of control transaction×

20 item(s) selected

News

Receive news related to Tonix Pharmaceuticals Holding Corp.

Track Activities on TNXP

Account